APA (7th ed.) Citation

Yamamoto, H., Soh, J., Okumura, N., Suzuki, H., Nakata, M., Fujiwara, T., . . . Toyooka, S. (2023). Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Yamamoto, Hiromasa, et al. Randomized Phase II Study of Daily Versus Alternate-day Administrations of S-1 for the Elderly Patients with Completely Resected Pathological Stage IA (tumor Diameter > 2 Cm)-IIIA of Non-small Cell Lung Cancer: Setouchi Lung Cancer Group Study 1201. Public Library of Science (PLoS), 2023.

MLA (9th ed.) Citation

Yamamoto, Hiromasa, et al. Randomized Phase II Study of Daily Versus Alternate-day Administrations of S-1 for the Elderly Patients with Completely Resected Pathological Stage IA (tumor Diameter > 2 Cm)-IIIA of Non-small Cell Lung Cancer: Setouchi Lung Cancer Group Study 1201. Public Library of Science (PLoS), 2023.